Bold Moves

Transform our go-to-market model

Lead the conversation

Pfizer drives mass awareness for Eucrisa®with integrated bold move celebrity partnership

Eucrisa (crisaborole) has been an established treatment option in Pfizer’s Inflammation & Immunology (I&I) therapeutic category since 2016, serving more than 600,000 patients worldwide. To break through the dermatology category and disrupt treatment complacency around eczema, the most common, chronic inflammatory skin disease that affects almost 18 million people in the U.S. alone, we needed a face – and voice – to address the condition in 2020.1,2

Pfizer partnered with mom, author, singer, fashion designer and eczema patient Jessica Simpson to encourage mild to moderate eczema patients to talk to their doctor about the condition and ask for Eucrisa by name. Simpson put a spotlight on the condition by announcing her eczema story for the first time on social media and sharing her experience with the masses through national media interviews to inspire hope among those with eczema.

Known for her honesty, Simpson is passionate about showing eczema warriors they are not alone.

I'm open about my insecurities and my flaws, and if I can help inspire anybody to feel better about themselves, that's why I'm here. I'm always out to empower women, empower people to feel better about themselves.​​​​​​​

Jessica Simpson

Mom, Author, Singer, Fashion Designer and Eczema Patient

The campaign response was overwhelming. Simpson’s eczema reveal captured the attention of national media and the eczema community, who rallied around her on social media to thank her for speaking about the condition.

“This campaign is another reminder that the breakthroughs we make – amplified by influential voices like Jessica’s – help enable freedom from day-to-day suffering for people living with chronic inflammatory diseases,” said Beatriz Faro, Regional President, I&I North America.

Eucrisa partnered with Simpson to inspire hope among those living with mild-to-moderate eczema and encourage them to take charge of their skin health.


1Bieber T. Atopic dermatitis. Dermatology. 2012;1(3):203-217.

2Hanifin JM, Reed ML. A population-based survey of eczema in the United States. Dermatitis. 2007;18(2):82-91. 

Discover more

Advances for a Potential First-in-Class Chronic OA Pain Treatment

Advancing Breakthroughs for Patients With NASH

Eucrisa, Now Starring Jessica Simpson

Working for Patients with Alopecia Areata

Advancing a Potential Breakthrough for Moderate to Severe Atopic Dermatitis

A Potentially Practice-Changing Approval in Advanced Urothelial Cancer

Addressing an Unmet Need for Certain Patients With BRAF-Mutant mCRC

Learning From Early Breast Cancer Studies to Drive Oncology Research Forward

Cancer Doesn’t Wait: Supporting Screenings During COVID-19

Positive Phase 1/2 Data at One Year for Hemophilia A Gene Therapy

Investigational Gene Therapy for Duchenne Muscular Dystrophy Achieves Exciting Milestones in 2020

Pfizer Vaccines Pipeline Includes Six Late-Stage Candidates

Pfizer Vaccines Launches​​​​​​​ Global Centers of Excellence Network

Progressing Maternal Vaccination Against Respiratory Syncytial Virus

Pfizer Pledges $100 Million Into New AMR Industry Fund

Partnering with Wellcome to Combat AMR in Sub-Saharan Africa

Expanding Access in China Through Health Insurance Innovation

Pfizer Invests in Biotechnology Innovation through the Pfizer Breakthrough Growth Initiative

Hospital Donations for COVID-19 Response

Pfizer Partners with BioNTech to Advance & Supply COVID-19 Vaccine​​​​​​​

Delivering on the Promise of Biosimilars

Driving Diversity in Our Research and Development​​​​​​​

Site Feature: Puurs, Belgium 

PGS Ingenuity Solves COVID-19 Cold Chain Storage Challenge​​​​​​​

Pfizer and Gilead Sciences Agree to Manufacture and Supply Remdesivir​​​​​​​

Key Medicine Supply and Public Policy During COVID-19

Pfizer Stands with Science

Five-Point Plan for Unprecedented Collaboration

COVID-19 Updates

Read the latest information about Pfizer’s COVID-19 vaccine on



Join the Conversation

Additional Information

Useful Links

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

Copyright © 2020-2021 Pfizer Inc.
All rights reserved

Explore our stories